Alexander N. Snel

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 449 citations · Full text

Medicine, Hematology, Oncology +16

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia

Monique Terwijn, Wendelien Zeijlemaker, Angèle Kelder et al. · PLoS ONE · 2014 · 213 citations · Full text

Medicine, Hematology, Oncology +17

CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Wendelien Zeijlemaker, Tim Grob, Rosa J. Meijer et al. · Leukemia · 2018 · 205 citations · Full text

Medicine, Hematology, Oncology +13

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Wendelien Zeijlemaker, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff et al. · Leukemia · 2015 · 123 citations · Full text

Medicine, Hematology, Oncology +17

The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse

Costa Bachas, Gerrit‐Jan Schuurhuis, Yehuda G. Assaraf et al. · Leukemia · 2012 · 97 citations

Medicine, Hematology, Oncology +17